Lundbeck to buy U.S. firm Chelsea Therapeutics for up to $658 mln

[Reuters] – * Consideration represents a 59 pct premium for Chelsea shares * Northera drug could become most valuable in Lundbeck’s portfolio -CEO * Deal still requires approval of Chelsea shareholders (Adds details, comments from management, analyst, sh more

View todays social media effects on CHTP

View the latest stocks trending across Twitter. Click to view dashboard

See who Chelsea is hiring next, click here to view